首页 / 院系成果 / 成果详情页

Targeting the contact-kinin system: A cyclopeptide with anti-thromboinflammatory properties against stroke  期刊论文  

  • 编号:
    2AFAF3505D4BAFBABF7C2776A67F311D
  • 作者:
    Wang, Wanting#[1,2,3]Zhang, Yan[1,2,3];Fang, Yuqing[2,3];Gao, Jinai[2,3];Thuku, Rebecca Caroline[2,3];Yang, Juan[4];Na, Chen[5];Lu, Qiumin[2,3];Fang, Mingqian*[2,3]
  • 语种:
    英文
  • 期刊:
    EUROPEAN JOURNAL OF PHARMACOLOGY ISSN:0014-2999 2025 年 998 卷 ; JUL 5
  • 收录:
  • 关键词:
  • 摘要:

    The contact-kinin system plays a central role in the thromboinflammatory pathology of ischemic stroke. Modulating this pathway represents a promising strategy for the prevention and treatment of ischemic stroke. Based on our recent findings demonstrating that the short peptide SD6 (SLGASD), derived from a specific influenza-related immunoglobulin heavy chain junction region sequence, exhibits anti-coagulant properties, we designed a cyclized version, cycloSD6, and evaluated its anti-ischemic stroke potential. Notably, cycloSD6 showed enhanced inhibition of activated coagulation factor XII (FXIIa; with an inhibition constant (Ki) of 41.27 mu M) and plasma kallikrein (PKa; Ki: 28.54 mu M), two key enzymes in the contact-kinin system, surpassing the inhibitory effects of its linear form. In vitro, 4-100 mu M of CycloSD6 inhibited LPS-induced inflammation. And CycloSD6 at doses of 1 and 4 mg/kg displayed significant anti-thrombotic functions in several mouse models, including carrageenan-induced tail thrombosis, FeCl3-induced arterial thrombosis, and cortical photothrombosis models, and did not affect mouse tail bleeding time. The peptide also exerted comparable anti-ischemic stroke effects to those of ecallantide (DX-88), a kallikrein inhibitor approved for the treatment of hereditary angioedema, in a mouse model of transient middle cerebral artery occlusion. Thus, this short peptide CycloSD6, which dual targets FXII and PKa, harbors anti-thromboinflammation and anti-stroke properties with low bleeding risk. And these findings suggest that cycloSD6 may serve as a potential therapeutic candidate or template for the development of agents targeting ischemic stroke.

  • 推荐引用方式
    GB/T 7714:
    Wang Wanting,Zhang Yan,Fang Yuqing, et al. Targeting the contact-kinin system: A cyclopeptide with anti-thromboinflammatory properties against stroke [J].EUROPEAN JOURNAL OF PHARMACOLOGY,2025,998.
  • APA:
    Wang Wanting,Zhang Yan,Fang Yuqing,Gao Jinai,&Fang Mingqian.(2025).Targeting the contact-kinin system: A cyclopeptide with anti-thromboinflammatory properties against stroke .EUROPEAN JOURNAL OF PHARMACOLOGY,998.
  • MLA:
    Wang Wanting, et al. "Targeting the contact-kinin system: A cyclopeptide with anti-thromboinflammatory properties against stroke" .EUROPEAN JOURNAL OF PHARMACOLOGY 998(2025).
  • 入库时间:
    2025/4/10 21:08:59
  • 更新时间:
    2025/5/29 22:36:19
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:6 下载次数:0
浏览次数:6
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部